NRGEX | VRSCX | NRGEX / VRSCX | |
Total Expense Ratio | 0.03 | 0.91 | 3% |
Annual Report Gross Expense Ratio | 0.69 | 0.91 | 76% |
Fund Existence | 4 years | 10 years | - |
Gain YTD | -2.228 | -2.115 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 9.27B | 171M | 5,423% |
Annual Yield % from dividends | 0.55 | 0.37 | 147% |
Returns for 1 year | -4.64 | -1.91 | 244% |
Returns for 3 years | 11.41 | 45.76 | 25% |
Returns for 5 years | N/A | 5.73 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
RAYD | 36.12 | 0.21 | +0.58% |
Rayliant Quantitative Dev Mkt Eq ETF | |||
PEJ | 57.77 | N/A | N/A |
Invesco Dynamic Leisure and Entmnt ETF | |||
BBC | 21.59 | N/A | N/A |
Virtus LifeSci Biotech Clinical Trls ETF | |||
OUNZ | 32.17 | -0.08 | -0.25% |
VanEck Merk Gold Trust | |||
FIXP | 19.73 | -0.05 | -0.25% |
FolioBeyond Enhanced Fixed Inc Prm ETF |